Lexington, KY, United States of America

Abeer M Al-Ghananeem

This inventor holds 4 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Ceptaris Therapeutics, Inc., New Millennium Pharmaceutical Research, Inc., US Worldmeds LLC. Active years: 2003-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abeer M Al-Ghananeem. Retrieved from https://idiyas.com/inventor/abeer-m-al-ghananeem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 170(Granted Patents)


Company Filing History:


Years Active: 2003-2015

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Abeer M Al-Ghananeem: Innovator in Pharmaceutical Solutions

Introduction

Abeer M Al-Ghananeem is a notable inventor based in Lexington, KY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative therapeutic agents. With a total of 4 patents to his name, Al-Ghananeem's work focuses on improving drug delivery systems and treatment methods.

Latest Patents

One of his latest patents is titled "Co-solvent compositions and methods for improved delivery of dantrolene therapeutic agents." This invention provides methods for using tert-butyl alcohol (TBA) co-solvent systems in the formulation of pharmaceutical agents with low solubility. The patent also details pharmaceutical compositions made using this novel co-solvent system. In one embodiment, the invention outlines a method for creating a dantrolene sodium (DS) formulation for intravenous use (DS-IV). This advancement represents a significant improvement in the pharmacotherapy of patients experiencing malignant hyperthermia during surgery.

Another recent patent is "Stabilized compositions of volatile alkylating agents and methods of using thereof." This invention focuses on a composition and method for treating cancer. It includes a Nitrogen Mustard or an HX salt of the Nitrogen Mustard, formulated in a non-aqueous vehicle or carrier that excludes petrolatum or ethanol. The method involves topically applying this composition to affected skin, enhancing treatment options for skin disorders.

Career Highlights

Throughout his career, Abeer M Al-Ghananeem has worked with various companies, including New Millennium Pharmaceutical Research, Inc. and Yaupon Therapeutics Inc. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Al-Ghananeem has collaborated with notable professionals in the field, including Robert Alonso and Peter Anthony Crooks. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Abeer M Al-Ghananeem is a distinguished inventor whose innovative contributions to pharmaceutical solutions have the potential to improve patient care significantly. His patents reflect a commitment to advancing therapeutic methods and enhancing drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…